The AIFM2 gene helps make a protein that protects cells from a form of damage called ferroptosis, where fats in the cell membrane are harmed by stress linked to iron. This gene plays an important role in helping cells stay alive during oxidative stress, which is wear and tear from unstable molecules. If the AIFM2 gene does not work well, cells may be more likely to die under stress, which can affect tissue health. In medicine, it draws interest because this pathway may influence cancer growth and injury in organs.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the information for producing proteins, the parts of cells that do the work. Others mainly control when certain processes take place, where they happen, and how strongly they run. As a whole, genes influence how the body develops and functions, and they can shape how you respond to food, stress, or medications. For a closer look at this topic, you can learn more in the LearnHub.
Overview
AIFM2Gene function
What if the gene works
The AIFM2 gene helps cells protect their fatty outer membranes from damage caused by harmful oxidation. Its protein helps recycle coenzyme Q10, which limits a form of cell death called ferroptosis.
Risk
What if the gene does not work
Changes in the AIFM2 gene can weaken the cell’s backup system against lipid damage and ferroptosis, a form of iron driven cell death. Milder variants may partly reduce this protection, while more severe variants can disrupt it much more.
Treatment
What does that mean for your treatment
No AIFM2-specific treatment or management approach is currently established for people with a pathogenic variant in the AIFM2 gene. In research, AIFM2 is being studied as a biomarker and drug target because it helps cells resist ferroptosis (an iron linked form of cell death) in some cancers.
Gene function
What if the gene works
In day to day cell life, the AIFM2 gene helps protect the fatty parts of cells from routine oxidative wear. It does this by making a protein that keeps key antioxidant molecules active at cell membranes. This supports steady cell function across many tissues.
The AIFM2 gene helps convert coenzyme Q10 into ubiquinol, its active antioxidant form. This gives cell membranes a ready way to neutralize harmful oxidation.
Its protein helps limit lipid peroxidation (damage to fats in cell membranes). This supports the structure and stability of the cell surface during everyday cell stress.
The AIFM2 gene provides a membrane based antioxidant system that works alongside other cell protection pathways. This extra layer of defense helps cells stay balanced and function normally.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the AIFM2 gene can change the protein's shape, stability, or placement in the cell, which may weaken how it recycles coenzyme Q, a molecule that helps limit damaging fat oxidation. How AIFM2 gene variants affect protein function depends on the change: milder variants may partly reduce activity, while more severe variants can sharply lower protein levels, disrupt key binding sites, or shorten the protein so it works little or not at all.
How variants are linked to conditions
Variants in the AIFM2 gene do not yet have a broadly confirmed link to a specific health condition, though research on AIFM2 gene variants and health conditions is still developing. Anyone with a confirmed AIFM2-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of being human, and they are common across the general population. Most do not have a direct effect on health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, one well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the AIFM2 gene. Risk, if a change is found, can depend on the exact variant and the health issue being evaluated. Anyone with concerns about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of AIFM2 variants
There is not yet a broadly confirmed, disease-associated Mendelian pattern for how AIFM2 gene variants are inherited, so the AIFM2 gene inheritance picture remains uncertain and may become clearer as research develops. The AIFM2 gene is located on chromosome 10, which is an autosome. That means you inherit one copy of the AIFM2 gene from your mother and one copy from your father.
What does my AIFM2 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for the AIFM2 gene, though this understanding can change as research develops. If you have a specific AIFM2 result and questions about what it could mean for your family, a doctor or genetic counselor can help explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the AIFM2 gene, a lab usually tests DNA from a blood draw or saliva sample. In genetic testing for AIFM2 variants, the lab reads the gene’s code and checks whether a variant is present. Results may show a benign variant, a disease-causing variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
There is not yet a broadly established AIFM2-specific reason for genetic testing in routine care. Decisions about testing are usually based on your personal health history, symptoms, and family history, together with a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic results can provide useful insight, although how much they reveal varies with the condition and the kind of variant involved. Over time, the way the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic finding may give a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. This helps explain why the same treatment may work well for one person, seem less effective for another, or cause more side effects in someone else. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. These differences are common and are one reason medication response is not the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies patterns between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence either how strongly a drug works or how the body processes it. This information can support more informed and more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the AIFM2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about medicines or side effects are best discussed with your doctor. Some early cancer research has looked at the AIFM2 gene because it may influence how cells respond to certain experimental treatments, but this is not used in routine prescribing.
History
The AIFM2 gene was first described in the late 1990s as a relative of the better known AIFM1 gene. Early reports focused on where it was active in the body and how it resembled other cell death related proteins. Scientific classifications changed as researchers learned more about the gene. A major shift came in 2019, when several research groups identified AIFM2 as ferroptosis suppressor protein 1, or FSP1, linking it to a newly recognized form of cell injury called ferroptosis. That finding quickly made the gene important in cancer and cell survival research. From these first observations, research expanded steadily. Today, AIFM2 is best known for how its role was redefined as this area of genetics matured.